Inflammation, Hyperglycemia, and Adverse Outcomes in Individuals With Diabetes Mellitus Hospitalized for COVID-19Alexi Vasbinder, Salim S. Hayek, Erinleigh Michaud et al.|Diabetes Care|2022Cited by 74
Increased soluble urokinase plasminogen activator levels modulate monocyte function to promote atherosclerosisGeorge Hindy, Salim S. Hayek, Daniel J. Tyrrell et al.|Journal of Clinical Investigation|2022Cited by 70
Angiotensin‐Converting Enzyme Inhibitors, Angiotensin II Receptor Blockers, and Outcomes in Patients Hospitalized for COVID‐19Michael Pan, Alexi Vasbinder, Élizabeth Anderson et al.|Journal of the American Heart Association|2021Cited by 29
SuPAR, biomarkers of inflammation, and severe outcomes in patients hospitalized for COVID‐19: The International Study of Inflammation in COVID‐19Alexi Vasbinder, Kishan Padalia, Ian Pizzo et al.|Journal of Medical Virology|2024Cited by 14